Fast Tracked Reviews Consumer Reports If you’re weighing whether Fast Tracked matters enough to pursue or to watch, the concise reason to consider Fast Tracked is that it creates a real pathway to faster review and earlier patient access without changing the safety and efficacy standards the FDA applies, and that practical combination is what makes Fast Tracked a useful tool in the regulatory toolbox. Fast Tracked brings together enhanced communication, rolling review, and eligibility for other expedited programs in a way that reduces regulatory uncertainty and shortens timelines when a drug addresses a serious condition with unmet needs, so anyone invested in getting safe, effective therapies to patients more quickly should understand how Fast Tracked can fit into development strategy. Fast Tracked is not a magic bullet — the underlying science, data quality, and trial execution still determine success — but when sponsors use Fast Tracked thoughtfully, aligning their development plans with FDA guidance and maintaining rigorous evidence standards, the designation can materially improve the odds of timely access for patients who need new treatment options.
Fast Tracked Reviews Consumer Reports Fast Tracked is granted after a sponsor requests the designation, which can happen any time after the Investigational New Drug application is on file and is often requested before the pre-NDA meeting; the FDA then reviews that request and provides a decision within 60 days, so when sponsors say their program was Fast Tracked they’re referring to a specific administrative decision and timeline. Fast Tracked drugs must meet two qualifying criteria: the drug must target a serious condition, which the FDA defines by potential impact on day-to-day functioning or survival, and the drug must demonstrate potential to address an unmet medical need — that could be because there is no current treatment, or because the new drug could offer a meaningful advantage such as greater effect on clinical outcomes, fewer or milder side effects, or better diagnostic capability. In practical terms, sponsors and stakeholders who say a candidate was Fast Tracked are describing a regulatory relationship where the FDA commits to closer engagement and the clock for potential approval can be materially shortened, with the ultimate goal of getting important therapies to patients sooner. Order Now Buy Fast Tracked Today